LSP (Life Sciences Partners)
Venture capitalAmsterdam · Series A–Late Stage · 8 people tracked
Investment thesis
EQT Life Sciences targets innovative life sciences companies globally, focusing on therapeutics, medical devices, diagnostics and healthtech. Drawing on a team of medical, scientific and industry experts, the firm seeks the most innovative solutions to the greatest unmet clinical needs, aiming to transform cutting-edge scientific innovation into impactful healthcare solutions while striving for superior investor returns. Beyond capital, it provides strategic, clinical, operational, financial and commercial guidance. With a 30-year track record, the firm has raised around 3.5 billion euros across 12 private funds and three investment strategies: Life Sciences Funds, Health Economic Funds and a Dementia Fund.
Source: firm website, verified Aug 3, 2026.
Team · 8 people
from the firm's website & public directories
What they invest in
from 4 of 6 portfolio companiesHealthtech ×3Medical Devices ×3Biotech ×2Deep Tech ×1Digital Health ×1Enterprise Software ×1
HQs:Belgium×1Netherlands×1Sweden×1
Investments · 6 tracked
founders shown can be your intro path
Developer of the EmboTrap stroke treatment device for removing clots from the brain; acquired by Johnson & Johnson.
PartnerRené R. Kuijten· led
NewAmsterdam Pharma develops innovative therapies for cardiovascular disease and lipid-related conditions.
BiotechHealthtechMedical Devices
PartnerPhilip Scheltens· led
Onera Health provides clinical-grade remote diagnostics and monitoring solutions for healthcare professionals, with an initial focus on sleep health.
Digital HealthHealthtechMedical DevicesEindhoven, NL
PanTera develops actinium-225, a therapeutic radioisotope used in precision cancer treatment through radiotheranostics, serving oncology patients and pharmaceutical companies globally.
BiotechDeep TechHealthtechMedical DevicesMol, BE
Sven van den berghe(CEO)Christophe Malice(CBO)Samy Bertrand(CTO)Yves Sterckx(Director of Finance & Administration)Philippe Vanwolleghem(Director Quality, Regulatory Affairs & HSE)
Frequently asked questions
- What stage does LSP (Life Sciences Partners) invest at?
- LSP (Life Sciences Partners) invests at the Series A, Series B, Series C, Growth, Late Stage stages.
- What is LSP (Life Sciences Partners)'s typical check size?
- LSP (Life Sciences Partners) typically writes checks of $10.8M – $64.8M.
- What sectors does LSP (Life Sciences Partners) focus on?
- LSP (Life Sciences Partners) focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is LSP (Life Sciences Partners) located?
- LSP (Life Sciences Partners) is headquartered in Amsterdam, NL.
- Does LSP (Life Sciences Partners) lead rounds?
- Yes, LSP (Life Sciences Partners) leads investment rounds.
Media · Podcasts & interviews
from their channelEQT Value Creation Day in London 2026
EQT
EQT AB Annual Shareholders' Meeting 2026
EQT
Per Franzen and Jean Eric Salata on CNBC's Squawk Box Asia
EQT
India's Investment Journey with Hari Gopalakrishnan
EQT
How Being an “Outsider” Could Give You an Inside Advantage
EQT
Stop Trying to Be Like Everyone Else, Says Our Founder
EQT
Similar investors
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
Lumira Ventures is a North American life sciences venture capital firm that partners with mission-driven entrepreneurs to build companies developing and commercializing healthcare products for patients.
OrbiMed is a global healthcare-focused investment firm providing financing and operational support to companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.
Foresite Capital is a multi-stage investment firm focused on healthcare and life sciences, backing companies across all stages of growth. It applies a data science-driven approach to invest in businesses leveraging biology and big data to transform healthcare.